Car T cell therapy has recently drawn a lot of attention for multiple sclerosis because of an instance of an experimental fix
The Food and Drug Administration (FDA) has endorsed another therapy called Cellecta, which utilizes T cells as part of a treatment for multiple sclerosis and other types of malignancy. Illusory antigen receptor T-cells are T cells that have been genetically designed in a laboratory to create an exact duplicate of themselves for use in cellular therapy. These cells are then injected into the body to fight malignancy. While there are currently no clinical trials testing this new treatment, doctors are optimistic that it might one day be accessible as an option for disease patients. The theory behind CAR T Cell Therapy depends on the possibility that an individual's insusceptible cells attack carcinogenic cells in the body, preventing them from multiplying. Since there is a mutation in a malignant growth cell that makes it multiply unreasonably, doctors accept that destroying these cells with T-cells will stop disease from spreading to other parts of the body. This type of l...